BlackRock, Inc. 13D and 13G filings for NGM Biopharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-10-06 2:34 pm Sale | 2023-09-30 | 13G | NGM Biopharmaceuticals, Inc. NGM | BlackRock Inc. BLK | 3,839,879 4.600% | -318,764 (-7.67%) | Filing |
| 2023-02-03 4:27 pm Purchase | 2022-12-31 | 13G | NGM Biopharmaceuticals, Inc. NGM | BlackRock Inc. BLK | 4,158,643 5.100% | 4,158,643 (New Position) | Filing |